Since 11 March 2020, The World Health Organization has characterized coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 () as a pandemic. The outbreak started in the city of Wuhan in China and quickly spread worldwide. Coronaviruses have previously caused two large-scale pandemics in the past two decades, SARS () and Middle East respiratory syndrome (MERS) (). SARS-CoV-2 is closely related to other CoV found in zoonotic reservoirs, such as bats, camels, and pangolins (). Since SARS-CoV-2 is considerably more infectious than both SARS-CoV and MERS-CoV, many countries have determined a strict policy of “shelter-in-place” to contain the virus spread through social contagion. However, many questions remain regarding the clinical outcomes of human infection by SARS-CoV-2, including the possibility of the development of neurological disorders ().
Some viruses possess a tropism for neural tissue and are thus classified as neurotropic (e.g., herpes simplex virus type 1, rabies virus). Those viruses enter the brain through various routes, including retrograde axonal transport along axons, hematogenous spread via the blood-brain barrier (BBB), blood-cerebrospinal fluid barrier, meningeal-cerebrospinal fluid barrier, via direct infection of endothelial cells or through spreading of infected leukocytes to the brain across the BBB (). Once in the brain, these viruses disrupt the complex organization of neural circuits either directly by neuronal damage or indirectly through host immune response pathways, causing immediate, or delayed neuropathology and neurological manifestations () (see below). In the short-term, neurotropic viral infections can cause inflammation of the brain parenchyma and lead to encephalitis or brain-targeted auto-immune responses in susceptible individuals (). Possible long-term effects on hosts can include alterations on emotional and cognitive behavior, as shown in experimental animals through persistent alterations in the expression of genes involved in the regulation of synaptic activities in key brain areas (). The axonal transport of neurotropic viruses can also turn intrinsically disordered proteins, such as α-synuclein (α-syn), into promiscuous binders that can form toxic aggregates and travel along neuronal pathways and cause cell death in areas of the brain ().
While the most common symptoms of COVID-19 at the onset of illness include fever, fatigue, dry cough, myalgia, and dyspnea, other less common symptoms are headache, abdominal pain, diarrhea, nausea, and vomiting (). Furthermore, it's been recently reported that most patients also complain of impairment of both olfactory and gustatory perception () and those are being considered early markers of COVID-19 infection. Though there is longstanding evidence that human coronaviruses, such as SARS-CoV-2, can spread to the brain from the respiratory tract (, , ), the occurrence of gastrointestinal symptoms () suggests that the gastrointestinal system is a possible route of invasion and transmission to the enteric nervous system (ENS) (see Figure 1). While the effects of COVID-2019 on olfactory and gustatory perception may be transient, the possibility that viruses and other contaminant agents can be the initiating etiology of neurodegenerative diseases such as Parkinson's disease (PD) has been raised before ().
Figure 1
Parkinson's disease (PD) is a common neurodegenerative disorder associated with the progressive loss of dopaminergic neurons located in the midbrain nucleus substantia nigra pars compacta (SNpc) due to the accumulation of α-synuclein (α-syn) aggregates. The Braak hypothesis () for the etiology of sporadic Parkinson's disease (PD) proposes that a neurotropic virus invading neural tissue through the nasal cavity and the gastrointestinal tract causes α-syn to turn into a promiscuous binder and be transmitted, prion-like, to key areas such as the SNpc (). Interestingly, the prodromal or preclinical phase of PD is also characterized by olfactory and gastrointestinal symptoms ().
The cellular receptor for SARS-CoV-2 is the angiotensin-converting enzyme 2 (ACE2), which has a role in the metabolism of angiotensin peptides involved in the control of vasoconstriction and blood pressure (). ACE2 is found in several tissues associated with cardiovascular function, but also in the brain, including brainstem nuclei involved with cardio-respiratory regulation (, ). Thus, respiratory problems in COVID-19 patients could also derive from the direct action of SARS-CoV-2 in respiratory control nuclei in the Brain (). Through its binding to ACE2 receptors, SARS-CoV-2 may spread transneuronally to distant brain targets, similar to other neurotropic viruses (), as predicted by the Braak hypothesis.
Thus, recovery may be an ambiguous term regarding COVID-19. Though recovery from the acute phase of the infections is certainly a relief in public health terms, helping to stop the spreading of the infection, one must consider the long-term neurological effects of the disease. This discussion has been conspicuously lacking in pertinent forums and needs to be adequately addressed as an important concern by public health officials. Many authorities are focusing only on the risks posed to the elderly and immunocompromised subjects, downplaying the threats to younger populations. Though the neurological risks described in the present work are particularly important to the elderly, due to age-related degenerative processes in the immunologic system and the brain, the population needs to be alerted to the chronic neurological risks during the pandemic and maintain social distancing for as long as it is necessary.
Statements
Author contributions
AP conceived and wrote the manuscript.
Funding
Financial support from Federal University of Pará (UFPA).
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
ZhouPYangX-LWangX-GHuBZhangLZhangWet al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020) 579:270–3. 10.1038/s41586-020-2012-7
2.
DrostenCGüntherSPreiserWvan der WerfSBrodtH-RBeckerSet al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. (2003) 348:1967–76. 10.1056/NEJMoa030747
3.
ZakiAMvan BoheemenSBestebroerTMOsterhausADMEFouchierRAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. (2012) 367:1814–20. 10.1056/NEJMoa1211721
4.
ZhangTWuQZhangZ. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol. (2020) 30:1346–51. 10.1016/j.cub.2020.03.022
5.
DesforgesMLe CoupanecADubeauPBourgouinALajouieLDubéMet al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?Viruses. (2019) 12:14. 10.3390/v12010014
6.
LudlowMKortekaasJHerdenCHoffmannBTappeDTrebstCet al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol. (2016) 131:159–84. 10.1007/s00401-015-1511-3
7.
SavarinCBergmannCC. Viral-induced suppression of self-reactive T cells: lessons from neurotropic coronavirus-induced demyelination. J Neuroimmunol. (2017) 308:12–6. 10.1016/j.jneuroim.2017.01.003
8.
BerakiSAronssonFKarlssonHÖgrenSOKristenssonK. Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol Psychiatry. (2005) 10:299–308. 10.1038/sj.mp.4001545
9.
BraakHRübUGaiWPDel TrediciK. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Trans. (2003) 110:517–36. 10.1007/s00702-002-0808-2
10.
WangDHuBHuCZhuFLiuXZhangJet al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. (2020) 323:1061–9. 10.1001/jama.2020.1585
11.
YeagerA. Lost Smell and Taste Hint COVID-19 Can Target the Nervous System. The Scientist Magazine (2020, March 24). Available online at: https://www.the-scientist.com/news-opinion/lost-smell-and-taste-hint-covid-19-can-target-the-nervous-system-67312 (accessed April 04, 2020).
12.
BohmwaldKGálvezNMSRíosMKalergisAM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. (2018) 12:386. 10.3389/fncel.2018.00386
13.
DingYHeLZhangQHuangZCheXHouJet al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. (2004) 203:622–30. 10.1002/path.1560
14.
GuJHanBWangJ. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. (2020). 10.1053/j.gastro.2020.02.054. [Epub ahead of print].
15.
FonsecaSde OliveiraHLYamadaESNevesBCPereiraA. The gut and Parkinson's disease—a bidirectional pathway. Front Neurol. (2020) 10:574. 10.3389/fneur.2019.00574
16.
JangHBoltzDAWebsterRGSmeyneRJ. Viral parkinsonism. Biochim Biophys Acta. (2009) 1792:714–21. 10.1016/j.bbadis.2008.08.001
17.
MahlknechtPSeppiKPoeweW. The concept of prodromal Parkinson's disease. J Parkinsons Dis. (2015) 5:681–97. 10.3233/JPD-150685
18.
YanRZhangYLiYXiaLYingyingGZhouQ. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. (2020) 367:1444–8. 10.1126/science.abb2762
19.
BaigAMKhaleeqAAliUSyedaH. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. (2020) 11:7. 10.1021/acschemneuro.0c00122
20.
DoobayMFTalmanLSObrTDTianXDavissonRLLazartiguesE. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Compar Physiol. (2007) 292:R373–81. 10.1152/ajpregu.00292.2006
21.
LiYCBaiWZHashikawaT. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. (2020). 10.1002/jmv.25728. [Epub ahead of print].
22.
McGavernDBKangSS. Illuminating viral infections in the nervous system. Nat Rev Immunol. (2011) 11:318–29. 10.1038/nri2971
Summary
Keywords
COVID-19, synucleinopathy, neurotropism, coronavirus (CoV), SARS-CoV
Citation
Pereira A (2020) Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic. Front. Neurol. 11:308. doi: 10.3389/fneur.2020.00308
Received
25 March 2020
Accepted
31 March 2020
Published
17 April 2020
Volume
11 - 2020
Edited by
Robert Weissert, University of Regensburg, Germany
Reviewed by
Michael Levy, Harvard Medical School, United States
Updates
Copyright
© 2020 Pereira.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Antonio Pereira apereira@ufpa.br
This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.